Cerliponase alfa (Brineura) for CLN2 Batten Disease

Type: drug

Status: FDA Approved, EMA Approved

Developer: BioMarin Pharmaceutical

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026